Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Cancer Prev Res (Phila). 2012 Apr 3;5(5):778–787. doi: 10.1158/1940-6207.CAPR-11-0551

Figure 3.

Figure 3

CPT activates p38/JNK and inhibits Erk1/2 in a concentration-and time-dependent manner. DU145 cells grown in 6-well plates were treated with CPT at indicated concentrations for 8 hours (A), or 10 μmol/L CPT for indicated time (B), followed by Western blot analysis with indicated antibodies.